Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
HilleVax, Inc. - Common Stock
(NQ:
HLVX
)
1.970
+0.030 (+1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HilleVax, Inc. - Common Stock
< Previous
1
2
3
Next >
HLVX Stock Earnings: HilleVax Misses EPS for Q2 2024
August 09, 2024
HLVX stock results show that HilleVax missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 08, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Reduction in Force
July 31, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 15, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
(HLVX) - Analyzing HilleVax's Short Interest
July 09, 2024
Via
Benzinga
HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023
March 20, 2024
HLVX stock results show that HilleVax beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 09, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Gold Falls Over 1%; HilleVax Shares Plunge
July 08, 2024
Via
Benzinga
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday?
July 08, 2024
U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record...
Via
Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 08, 2024
Via
Benzinga
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
July 08, 2024
Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares.
Via
InvestorPlace
Why Is HilleVax (HLVX) Stock Down 87% Today?
July 08, 2024
HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants.
Via
InvestorPlace
HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm
July 08, 2024
From
The Schall Law Firm
Via
Business Wire
Dow Turns Lower; Myomo Shares Jump
July 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results
July 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: HilleVax Q4 Earnings
March 20, 2024
Via
Benzinga
Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why
July 08, 2024
Shares of HilleVax fell after the release of Phase 2b trial results for HIL-214, a vaccine for norovirus-related acute gastroenteritis in infants. The study showed 5% efficacy and no significant...
Via
Benzinga
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
July 08, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
June 04, 2024
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024
May 09, 2024
HLVX stock results show that HilleVax missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 09, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
March 20, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
February 05, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
January 18, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
January 13, 2024
Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will...
Via
Talk Markets
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
January 08, 2024
Collaboration leverages HilleVax’s leading norovirus vaccine development expertise and adds a Phase 1-ready next-generation program to HilleVax’s pipeline
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 09, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.